Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Results from an insight review commissioned by the Wellcome Trust, highlights what is currently known about the benefits and risks of using selective serotonin reuptake inhibitors (SSRIs) for the treatment of depression and anxiety in young people.

A boy in a hoodie sitting on a beach looking out to sea

One of a series of Wellcome Trust reviews of the active ingredients of interventions to prevent/treat depression and anxiety in young people was carried out by the team in the Psychopharmacology and Emotion Research Laboratory (PERL) at the Department of Psychiatry, University of Oxford. They reviewed the literature about the use of antidepressants in young people aged 14-24 years, and held a series of online workshops with young people with lived experience, which were supported by the McPin Foundation and the NEUROSEC (Neuroscience, Ethics and Society) Young People Advisory Group. 

Dr Susie Murphy, Department of Psychiatry, said,

There is understandable disquiet about the use of antidepressants in young people and yet there are also significant risks associated with under-treating severe depression in this age group. It is important to understand the effects antidepressants have in young people so that they can make informed choices about the best treatment approach for them. 

A recent blog - Antidepressants and psychotherapy for adolescent depression: can they be compared? #ActiveIngredientsMH.

A new animation created with contributions from young people with lived experience from the McPin Foundation and NEUROSEC - Antidepressants for young people with depression and anxiety.

Listen to a podcast with Professor Catherine Harmer and Dr Susie Murphy discussing the knowns and unknowns of antidepressant effects in young people with the Mental Elf.

For more information about the work of PERL.

NIHR OXFORD HEALTH BIOMEDICAL RESEARCH CENTRE NEWS

Please follow the link below to read the news on the NIHR BRC website.

Similar stories

Treating mental illness with electricity - new podcast

A new wave of treatments that stimulate the brain with electricity are showing promise on patients and in clinical trials.

Hours of gaming not negatively impacting wellbeing of most adolescents - new study

University of Oxford researchers found that although many school-age adolescents are spending considerable time gaming, it is not having a negative impact on their wellbeing.

Few mental health apps make it to real world, according to new Oxford University study

Despite enthusiasm for digital technology in addressing young people’s mental health, few effective apps have been successfully rolled out.

Oxford gets £122m funding for healthcare research

Health and care research in Oxford is to receive £122 million in government funding over the next five years to improve diagnosis, treatment and care for NHS patients.

Dementia research - new trial with diabetes drug

An important new trial will test the effects of oral semaglutide on the build-up of a protein in the brain that characterises Alzheimer's disease.